PANAXIA LABS ISRAE (PNAX.TA) Financials
PNAX.TA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 22.0 million | 49.2 million |
| 2022-12-31 | 39.7 million | 61.9 million |
| 2022-09-30 | 52.5 million | 63.1 million |
| 2022-06-30 | 66.0 million | 63.8 million |
PNAX.TA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-06-30 | ? | ? |
| 2022-12-31 | -1.1 million | -176000 |
| 2022-09-30 | -9.8 million | 176000 |
| 2022-06-30 | 654000 | -119000 |
PNAX.TA Net Income
No data available :(
PNAX.TA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | - | - | 345000 |
| 2022-12-31 | - | - | 1.4 million |
| 2022-09-30 | - | - | 1.7 million |
| 2022-06-30 | - | - | 2.1 million |
PNAX.TA Shares Outstanding
PNAX.TA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | - | - | - | - |
| 2022-12-31 | 12000 | - | 6.9 million | - |
| 2022-09-30 | 98000 | - | 4.1 million | - |
| 2022-06-30 | 126000 | - | 4.0 million | - |
PNAX.TA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | - | - |
| 2022-12-31 | 5.6 million | 16.3 million |
| 2022-09-30 | 10.6 million | 15.0 million |
| 2022-06-30 | 9.5 million | 13.7 million |
PNAX.TA
Price: ILA9,414
52 week price:
Earnings Per Share: -89.00 ILA
P/E Ratio: -0.46
Exchange: TLV
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 962296
Market Capitalization: 14.4 million